REGN Insider Trading

Regeneron Pharmaceuticals, Inc. (REGN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $98.82B, listed on NASDAQ, employing roughly 15,410 people, carrying a beta of 0.24 to the broader market. Regeneron Pharmaceuticals, Inc. Led by Leonard S. Schleifer, public since 1991-04-02.

In the last 12 months, Regeneron Pharmaceuticals, Inc. insiders made 0 buy transactions and 134 sale transactions.

DateNameTypeSharesPriceValue
Nov 6, 2026Pitofsky JasonM-Exempt905$492.00$445.3K
Nov 6, 2026Pitofsky JasonS-Sale439$939.57$412.5K
Nov 6, 2026Pitofsky JasonM-Exempt1,478$644.54$952.6K
Nov 6, 2026Pitofsky JasonS-Sale575$940.46$540.8K
Nov 6, 2026Pitofsky JasonS-Sale982$941.58$924.6K
Nov 6, 2026Pitofsky JasonM-Exempt1,500$726.53$1.1M
Nov 6, 2026Pitofsky JasonS-Sale1,215$942.31$1.1M
Nov 6, 2026Pitofsky JasonS-Sale529$943.53$499.1K
Nov 6, 2026Pitofsky JasonS-Sale108$944.22$102.0K
Nov 6, 2026Pitofsky JasonS-Sale35$945.61$33.1K

REGN Insider Activity by Quarter

Reported Form 4 and Form 5 lines under REGN's own SEC company ID, by transaction date, back to Q4 2024. Purchases and sales are code P / S (open market or private) in the company's shares; other lines are purchases and sales of other securities (options, warrants, preferred), awards, exercises, tax withholding, gifts and other acquisitions and dispositions. Later filings and amendments can change the current quarter. Earlier quarters are not shown: the filings read reach back to Jun 10, 2024, and a quarter counts only when every filing for it was read. Last refreshed Nov 7, 2026.

QuarterPurchasesBoughtSalesSoldOther Lines
Q4 2026 (so far)0N/A57$49.6M29
Q3 20260N/A6$3.4M12
Q2 20260N/A21$148.3K0
Q1 20260N/A49$4.2M28
Q4 20250N/A8$5.1M49
Q3 20250N/A0N/A0
Q2 20250N/A0N/A0
Q1 20250N/A0N/A22
Q4 20240N/A19$2.0M35

REGN Institutional Ownership (13F)

As of Jun 30, 2026 (Q2 2026), 1,332 institutions reported holding 91,588,748 REGN shares, valued at $58.21B as reported, 88.4% of its market cap (market cap of Jun 26, 2026). That is -67 institutions from the quarter before. Among managers whose reports for both quarters are comparable, 101 opened a position, 148 closed one, 485 added and 538 trimmed.

Top Holders, Q2 2026

ManagerSharesValueChange
BlackRock, Inc.9,113,506$5.68B+165,771
VANGUARD CAPITAL MANAGEMENT LLC6,629,759$4.13B-25,154
Dodge & Cox4,871,137$3.04B+412,899
STATE STREET CORP4,834,688$3.01B+170,210
Invesco Ltd.3,940,665$2.46B+35,556
JPMORGAN CHASE & CO3,774,199$2.38B-537,607
VANGUARD PORTFOLIO MANAGEMENT LLC3,175,313$1.98B+1,454,539
FRANKLIN RESOURCES INC2,771,839$1.73B+49,768
GEODE CAPITAL MANAGEMENT, LLC2,625,810$1.63B+18,078
Nuveen, LLC2,019,974$1.26B-45,090

By Quarter

QuarterInstitutionsSharesValue
Q2 20261,33291,588,748$58.21B
Q1 20261,39990,530,184$69.79B
Q4 20251,38691,899,708$70.94B
Q3 20251,24291,186,731$51.26B
Q2 20251,19789,664,322$47.10B
Q1 20251,27491,922,741$58.26B
Q4 20241,30093,428,563$66.59B
Q3 20241,36899,843,936$103.75B
Q2 20241,310103,770,775$109.03B

From the SEC's Form 13F data sets: investment managers with $100 million or more in Section 13(f) securities report their holdings each quarter, up to 45 days after it ends; a restated filing replaces the original, and values are as the managers reported them (a position whose price runs about 1,000 times below other managers', from a manager whose positions mostly do, is read as reported in thousands of dollars). The same shares can be reported by more than one manager, so totals can count some twice.

ETFs Holding REGN

FundWeight of REGNShares (as reported)Value (as reported)Source updated
QQQ Invesco QQQ Trust, Series 10.44%2,149,778$2.06BNov 12, 2026
IVV iShares Core S&P 500 ETF0.14%1,316,130$1.26BNov 12, 2026
SPY State Street SPDR S&P 500 ETF0.14%1,206,418$1.16BNov 12, 2026
IBB iShares Biotechnology ETF6.43%763,426$732.4MNov 12, 2026
XLV State Street Health Care Select Sector SPDR ETF1.37%728,183$698.6MNov 12, 2026
JEPI JPMorgan Equity Premium Income ETF1.09%534,143$512.5MNov 12, 2026
RDVY First Trust Rising Dividend Achievers ETF1.93%522,538$501.3MNov 12, 2026
QQQM Invesco NASDAQ 100 ETF0.44%495,156$475.1MNov 12, 2026
SPYM State Street SPDR Portfolio S&P 500 ETF0.14%278,754$267.0MNov 12, 2026
JEPQ JPMorgan Nasdaq Equity Premium Income ETF0.62%273,626$262.5MNov 12, 2026
RSP Invesco S&P 500 Equal Weight ETF0.23%251,538$241.3MNov 12, 2026
IWD iShares Russell 1000 Value ETF0.25%218,448$209.6MNov 12, 2026
XBI State Street SPDR S&P Biotech ETF1.72%193,184$185.3MNov 12, 2026
SCHG Schwab U.S. Large-Cap Growth ETF0.26%168,398$160.2MNov 13, 2026
IVE iShares S&P 500 Value ETF0.30%164,625$157.9MNov 12, 2026

From each fund's latest holdings file on record that shows REGN's listed security itself. A file counts when its line count is consistent with the fund's reported holdings count (at most twice it plus 10, or at most 1,000 lines for a reported count of exactly 10, which the data source gives many funds as a cap), read with that file or inherited from the fund's last classified file (within 20% of its line count, read within 60 days). Funds whose line for the company could not be confirmed as REGN's listed security, or that hold it through underlying funds (look-through), are not listed. Only long positions count: a fund is left out when any of its lines for REGN reports a negative weight, share count or value, or none of them above zero (a short position, or figures that disagree). Shares, value and weight are as reported in each fund's file, dated by the data source's last update of that file (not the date of the positions); the weight is REGN's share of that fund.

REGN Congress Trades

Members of Congress and their households disclosed 57 transactions in REGN on file (26 purchases, 31 sales) by 14 members, the latest trade on Oct 7, 2026. The newest 10 are below.

MemberChamberTypeAmountTradedDisclosed
Ro Khanna (D-CA-17)HousePurchase$1,001 - $15,000Oct 7, 2026Nov 9, 2026
Ro Khanna (D-CA-17)HouseSale$1,001 - $15,000Sep 4, 2026Oct 9, 2026
Ro Khanna (D-CA-17)HousePurchase$1,001 - $15,000Jul 7, 2026Aug 12, 2026
Gilbert Ray Cisneros, Jr. (D-CA-31)HouseSale (Full)$1,001 - $15,000May 15, 2026Jun 9, 2026
Ro Khanna (D-CA-17)HousePurchase$1,001 - $15,000Apr 13, 2026May 13, 2026
Alan Armstrong (R-OK)SenatePurchase$1,001 - $15,000Mar 27, 2026Jul 21, 2026
Julia Letlow (R-LA-5)HousePurchase$1,001 - $15,000Feb 12, 2026Mar 13, 2026
Ro Khanna (D-CA-17)HouseSale$1,001 - $15,000Jan 29, 2026Feb 10, 2026
Gilbert Ray Cisneros, Jr. (D-CA-31)HousePurchase$1,001 - $15,000Nov 18, 2025Dec 15, 2025
Ro Khanna (D-CA-17)HouseSale$1,001 - $15,000Sep 29, 2025Oct 3, 2025

From the periodic transaction reports members of the Senate and the House file under the STOCK Act, within 45 days of a trade (some file later); amounts are the ranges the reports give (a few give an exact amount), and a transaction a later report lists again is counted once. On file: House reports disclosed from Apr 10, 2023 through Nov 13, 2026; Senate reports disclosed from Jan 30, 2014 through Nov 4, 2026. The party is the member's on the trade date. A trade is listed under the company that traded under its ticker on the trade date (dated from Feb 1, 2021, unless the filing describes another company of ours; before that, only when the filing's description of the security is the company's name).

How to Read REGN Insider Activity

Net insider sentiment skews to the sell side over the trailing twelve months: 134 sales versus 0 buys. Insider sales carry less informational weight than buys because they are often driven by liquidity, tax planning, or pre-scheduled Rule 10b5-1 trading plans rather than negative information. The transaction type alone does not say whether a sale was made on the open market or privately, or under a 10b5-1 plan; the filing's plan checkbox and footnotes do. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.

Learn how insider trading is reported and how to read the data →

Frequently asked REGN insider trading questions

How active are REGN insiders right now?
Over the trailing twelve months, Regeneron Pharmaceuticals, Inc. (REGN) insiders made 0 buy transactions and 134 sale transactions. Net insider sentiment over the trailing twelve months tilts to the sell side (134 sales vs 0 buys). The transaction list above shows the most recent filings; each entry includes the insider's name, transaction type, share count, and per-share price.
What counts as an insider transaction?
Section 16 of the Securities Exchange Act requires officers, directors, and 10% beneficial-owner shareholders to disclose changes in their holdings via Form 3 (initial statement), Form 4 (subsequent transactions, filed within two business days), and Form 5 (annual catch-up). Insider transactions cover open-market purchases and sales, exercise of stock options, gifts, and grants. The "transaction type" field on each row distinguishes these subcategories.
Are REGN insider buys a bullish signal?
Insider purchases (Type P, made on the open market or privately; the code covers both) carry more informational weight than insider sales: an insider must commit personal capital, and the SEC scrutinizes purchases under Rule 10b5-1 for material non-public information. Sales, by contrast, are often driven by liquidity, tax planning, or pre-scheduled 10b5-1 trading plans rather than negative information. Cluster buying (multiple insiders buying within a short window) is a stronger signal than isolated buys.
How do REGN insider transactions affect options pricing?
Insider transaction data does not directly drive implied volatility, but Form 4 disclosures can move single-name IV if the size or timing is unusual (e.g. a large CEO buy ahead of an earnings window). Options markets price the marginal informational content; routine transactions under pre-scheduled plans are typically ignored. For event-driven options sizing, pair the insider transaction history with the upcoming earnings calendar.